A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment
Clinical trial NCT01468077 · COMPLETED
Trial details
- NCT number
- NCT01468077
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-09-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.